Skip to main content
Clinical Trials/ITMCTR1900002857
ITMCTR1900002857
Recruiting
Phase 1

Evaluation of the clinical effect of visualized neuromodulation in the Traditional Chinese Medicine treatment of limb dysfunction in stroke patients

Affiliated Hospital of Nanjing University of Chinese Medicine0 sitesTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Affiliated Hospital of Nanjing University of Chinese Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Affiliated Hospital of Nanjing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients with stroke according to the criteria of both western medicine and confirmed by head CT or MRI with stable vital signs;
  • 2\. Patients with stroke according to the criteria of Traditional Chinese Medicine, Aged between 18 and 85 years, cerebral hemorrhage or cerebral infraction for the first time,time since stroke of 2 weeks at least with hemiplegia
  • 3\. stable vital signs,no progress within 48 hours,Glasgow Co\-ma Scale\>8 points;
  • 4\. clinical feature is hemiplegia,the UK Medical Research Council between 0 and 3 level;
  • 5\. Clear awareness, can cooperate with treatment, can express feelings and follow instructions;
  • 6\. Relatively fixed address or telephone number, which can be followed up for a long time;
  • 7\. Those who voluntarily participated in the research project and signed the informed consent and the process of obtaining informed consent shall be in accordance with the provisions of GCP.

Exclusion Criteria

  • 1\. Patients who could not meet the above standards;
  • 2\. Patients with transient ischemic attack, progressive stroke, massive cerebral infarction and massive cerebral hemorrhage;
  • 3\. Patients with severe mental disorders;
  • 4\. Patients with moderate or above dementia and can notcooperate with treatment;
  • 5\. Patients with previous heart tremor, rheumatic heart disease and other diseases that are easy to lead to embolus falling off;
  • 6\. Patients with severe heart, liver and kidney dysfunction and shock;
  • 7\. Patients with tumor, pregnancy and coagulation disorders.

Outcomes

Primary Outcomes

Not specified

Similar Trials